Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06752616
PHASE2/PHASE3

Acute Agitation in Emergency Psychiatry

Sponsor: Lone Baandrup

View on ClinicalTrials.gov

Summary

The purpose of the study is to improve the pharmacological treatment of psychiatric patients with acute agitation.

Official title: Advancing the Quality of Treatment and Care for Acute Agitation in Emergency Psychiatry

Key Details

Gender

All

Age Range

18 Years - 64 Years

Study Type

INTERVENTIONAL

Enrollment

132

Start Date

2024-12-30

Completion Date

2027-12

Last Updated

2025-01-01

Healthy Volunteers

No

Conditions

Interventions

DRUG

Sublingual Dexmedetomidine

Sublingual dexmedetomidine 180 mcg, possible second dose 90 mcg after 2 hrs

DRUG

Buccal midazolam

Buccal midazolam 10 mg, possible second dose 10 mg after 2 hrs

DRUG

Oral lorazepam

Oral lorazepam 4 mg, possible second dose 4 mg after 2 hrs

Locations (1)

Mental Health Center Copenhagen, Bispebjerg

Copenhagen N, Denmark